Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cegedim | C7E | Jan 17, 2025 | 12.25 | -3.54 |
Cel-Sci Corp. | LSRM | Jan 17, 2025 | 0.38 | -0.78 |
Celanese Corp | DG3 | Jan 17, 2025 | 69.58 | +1.28 |
Celestica, Inc. | CTW0 | Jan 17, 2025 | 109.00 | +0.93 |
CELL IMPACT AB | ICLA | Jan 17, 2025 | 0.01 | 0.00 |
CellaVision | C26 | Jan 17, 2025 | 19.24 | +0.84 |
Cellcom Israel Limited | F5U | Jan 17, 2025 | 6.95 | +13.93 |
Celldex Therapeutics, Inc. | TCE2 | Jan 17, 2025 | 22.00 | 0.00 |
Cellectar Biosciences | NV4 | Jan 17, 2025 | 0.20 | +19.05 |
Cellectis | ZVA | Jan 17, 2025 | 1.53 | -6.36 |
Cellectis S.A. - American Depositary Shares | ZVAA | Jan 17, 2025 | 1.49 | -6.29 |
CELLINK B | 49Z | Jan 17, 2025 | 2.90 | +11.78 |
Cellnex Telecom S.A. | 472 | Jan 17, 2025 | 31.34 | +0.77 |
Cellnex Telecom SA Unsponsored ADR (Spain) | 4720 | Jan 17, 2025 | 15.20 | +3.40 |
Cellular Goods Plc | 6XS | Jan 17, 2025 | 0.00 | +25.00 |
Celon Pharma SA | 8RP | Jan 17, 2025 | 5.65 | +0.36 |
Celsion Corporation | CBO | Jan 17, 2025 | 0.85 | +1.18 |
Celsius Resources Limited | FX8 | Jan 17, 2025 | 0.01 | 0.00 |
Celtic plc | CCP | Jan 17, 2025 | 2.04 | +9.68 |
Celyad Oncology | 1C0 | Jan 17, 2025 | 0.57 | +18.75 |
Cemat | 1X9 | Jan 17, 2025 | 0.12 | -0.80 |
CEMBRE S.P.A. EO 0,52 | J0L | Jan 17, 2025 | 40.75 | +0.87 |
Cementir Holding N.V. | 3PC | Jan 17, 2025 | 11.00 | +0.37 |
Cementos Pacasmayo S.A.A. American Depositary Shares (Each r | EPCC | Jan 17, 2025 | 5.50 | -0.90 |
Cemex S.A.B. De C.V. | CEXA | Jan 17, 2025 | 5.25 | -1.87 |
Cemex S.A.B. De C.V. CPO | CEXB | Jan 17, 2025 | 0.52 | -1.90 |
Cenergy Holdings | 9CN | Jan 17, 2025 | 9.37 | -1.68 |
Cenit AG | CSH | Jan 17, 2025 | 7.85 | +1.95 |
Cenovus Energy Inc | CXD | Jan 17, 2025 | 14.39 | -0.98 |
Cenovus Energy Inc PRF PERPETUAL CAD - Ser 1 | CXD0 | Jan 17, 2025 | 14.40 | -0.69 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.